BioCryst Pharmaceuticals Inc (BCRX)
BioCryst Announces Sale of European ORLADEYO®(berotralstat) Business to Neopharmed Gentili for up to $264 Million
BioCryst Announces Sale of European ORLADEYO®(berotralstat) Business to Neopharmed Gentili for up to $264 Million
There are no comments here yet...